Bristol-Myers Squibb Appoints Fouad Namouni, M.D., Oncology Development Head
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Bristol-Myers Squibb (BMY), Janssen Enter New Immuno-Oncology-Focused Research Collaboration
July 26, 2016 7:00 AM EDTBristol-Myers Squibb Company (NYSE: BMY) announced a new clinical research collaboration with Janssen Biotech, Inc. to evaluate Bristol-Myers Squibbs Immuno-Oncology (I-O) agent... More
